NUVB – nuvation bio inc. class a (US:NASDAQ)

News

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
Nuvation Bio to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
Nuvation Bio to Present at the Jefferies London Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com